The Effect of Food or Sucralfate on the Bioavailability of S(+) and R(−) Enantiomers of Ibuprofen
Journal Articles
Overview
Research
Identity
Additional Document Info
View All
Overview
abstract
This randomized, multiple cross‐over pharmacokinetic study was undertaken to determine if food or sucralfate alter the bioavailability of the active S(+) enantiomer of Ibuprofen. Eleven healthy adult male volunteers were given three single 600‐mg doses of ibuprofen (separated by 1 week) administered either in a fasting state, after a standardized breakfast, or with sucralfate 1 g. The main outcome measures were area under the concentration (AUC), maximum peak plasma concentration (Cmax), and time to reach peak concentration (tmax) for total, S(+), and R(−) enantiomer serum ibuprofen levels, drawn up to 10 hours after dosing. The AUC for R(−) ibuprofen was significantly lower than S(+) ibuprofen in all three treatment groups. The treatments had no different effects on AUC for S(+), R(+), or total ibuprofen. There was no difference in the ratio of S(+):R(−) enantiomers across different treatment groups, but the intersubject variability was significant (P <.05). The S(+) ibuprofen Cmax was greater than the R(−) ibuprofen Cmax for ail treatment groups (P <.05). Sucralfate reduced the peak concentration of both S(+) and R(−) enantiomers when compared with fasting (P <.05). There was a slight but nonsignificant increase in the mean time to achieve peak concentration of both S(+) and R(−) enantiomers. Neither food nor sucralfate has a significant effect on ibuprofen enantiomer pharmacokinetics, but interindividual variability contributes significantly to the variability of enantiomer bioavailability.
